Korea Arlico Pharm Co.,Ltd. (KOSDAQ: 260660)

Korea Arlico Pharm Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13,511	19,066	23,395	9,520	5,506	12,041
Short-Term Investments	124.77	6,164	6,512	13,612	10,544	16,577
Trading Asset Securities	4,040	5,560	2,296	5,616	3,466	8,554
Cash & Short-Term Investments	17,677	30,790	32,203	28,747	19,516	37,172
Cash Growth	-36.77%	-4.39%	12.02%	47.30%	-47.50%	7.90%
Accounts Receivable	23,970	22,362	19,886	19,304	19,207	19,964
Other Receivables	229.13	46.58	110.46	74.88	151.41	313.29
Receivables	24,200	22,409	19,997	19,379	19,359	20,277
Inventory	31,566	26,779	27,437	19,759	18,918	12,567
Prepaid Expenses	-	7.97	7.25	5.78	7.23	6.95
Other Current Assets	2,702	3,570	2,479	964.07	184.17	75.72
Total Current Assets	76,144	83,555	82,123	68,855	57,984	70,099
Property, Plant & Equipment	66,125	66,740	49,726	31,641	26,661	19,443
Long-Term Investments	10,292	10,137	9,313	12,168	9,367	4,367
Other Intangible Assets	7,224	7,013	6,958	3,967	4,402	3,828
Long-Term Accounts Receivable	-0	-0	0	0	0	-0
Long-Term Deferred Tax Assets	5,395	4,365	4,071	3,741	2,834	2,381
Other Long-Term Assets	993.19	1,666	1,344	688.89	9,040	18,636
Total Assets	166,174	173,477	153,536	121,062	110,288	118,754
Accounts Payable	7,259	4,851	4,806	5,111	3,365	4,808
Accrued Expenses	8,881	11,868	12,407	10,038	342	896.94
Short-Term Debt	40,303	39,330	25,064	10,262	4,220	13,384
Current Portion of Long-Term Debt	421.7	-	2,000	191.4	3,216	3,533
Current Portion of Leases	219.33	152.42	151.35	82.2	41.57	-
Current Income Taxes Payable	-	-	883.22	840.4	982.53	1,205
Current Unearned Revenue	-	-	2.46	-	-	-
Other Current Liabilities	12,110	14,119	11,944	7,244	14,812	13,061
Total Current Liabilities	69,195	70,320	57,258	33,770	26,980	36,887
Long-Term Debt	6,324	6,746	3,746	2,000	2,191	7,708
Long-Term Leases	146.98	61.2	135.05	65.21	33.16	142.92
Other Long-Term Liabilities	7,979	7,275	3,851	3,370	3,270	2,977
Total Liabilities	83,645	84,402	64,990	39,933	32,721	47,468
Common Stock	7,664	7,664	7,664	7,664	4,911	4,880
Additional Paid-In Capital	40,143	40,143	40,143	40,143	42,919	42,438
Retained Earnings	37,197	43,743	43,156	35,904	31,983	25,690
Treasury Stock	-3,082	-3,082	-3,082	-3,082	-2,536	-2,074
Comprehensive Income & Other	608.09	608.09	665.54	501.14	290.23	351.26
Shareholders' Equity	82,529	89,075	88,546	81,129	77,566	71,286
Total Liabilities & Equity	166,174	173,477	153,536	121,062	110,288	118,754
Total Debt	47,415	46,289	31,096	12,601	9,702	24,767
Net Cash (Debt)	-29,739	-15,499	1,107	16,146	9,814	12,405
Net Cash Growth	-	-	-93.14%	64.53%	-20.89%	321.31%
Net Cash Per Share	-1980.89	-919.90	73.29	1071.03	650.58	1242.87
Filing Date Shares Outstanding	15.01	15.01	15.01	15.01	14.36	15.09
Total Common Shares Outstanding	15.01	15.01	15.01	15.01	14.36	15.09
Working Capital	6,949	13,235	24,865	35,085	31,004	33,213
Book Value Per Share	5497.04	5933.04	5897.81	5403.78	5400.05	4722.76
Tangible Book Value	75,305	82,062	81,588	77,162	73,164	67,458
Tangible Book Value Per Share	5015.84	5465.90	5434.34	5139.54	5093.59	4469.17
Land	-	11,406	10,188	9,607	7,151	5,421
Buildings	-	30,181	12,824	15,655	14,011	8,401
Machinery	-	31,527	8,822	15,961	14,075	2,853
Construction In Progress	-	10,784	16,418	1,608	584.85	866.35

Source: S&P Capital IQ. Standard template. Financial Sources.